当前位置:首页 - 行情中心 - 卫光生物(002880) - 财务分析

卫光生物

(002880)

  

流通市值:63.60亿  总市值:63.82亿
流通股本:2.26亿   总股本:2.27亿

卫光生物(002880)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2025年第一季度实现净利润0.44亿元,每股收益0.19元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2025年第一季度最新股东权益228796.00万元,未分配利润127028.82万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2025年第一季度最新总资产329068.40万元,负债100272.40万元。

利润表
报告期2025-03-312024-12-312024-09-302024-06-30
营业总收入225,002,020.971,203,192,257.65854,101,695.51522,902,745.97
营业总成本175,409,771.72900,123,198.06639,313,587.41392,463,709.82
营业利润53,314,969.08296,623,539.51217,276,259.92131,796,653.83
利润总额53,030,234.88296,735,138.91216,653,689.69131,335,735.48
净利润43,723,532.62253,956,996.52182,526,379.42109,727,347.83
其他综合收益----
综合收益总额43,723,532.62253,956,996.52182,526,379.42109,727,347.83
资产负债表
报告期2025-03-312024-12-312024-09-302024-06-30
流动资产合计1,534,646,0951,527,590,386.51,439,940,355.731,383,564,452.1
非流动资产合计1,756,037,909.061,769,853,846.691,731,267,580.761,694,840,660.54
资产总计3,290,684,004.063,297,444,233.193,171,207,936.493,078,405,112.64
流动负债合计412,720,588.19422,753,404.48370,562,358.45366,326,742.09
非流动负债合计590,003,418.08630,454,363.54627,840,068.24612,071,892.35
负债合计1,002,724,006.271,053,207,768.02998,402,426.69978,398,634.44
归属于母公司股东权益合计2,255,193,500.992,211,425,331.142,140,609,538.842,067,770,830.34
股东权益合计2,287,959,997.792,244,236,465.172,172,805,509.82,100,006,478.2
负债和股东权益合计3,290,684,004.063,297,444,233.193,171,207,936.493,078,405,112.64
现金流量表
报告期2025-03-312024-12-312024-09-302024-06-30
经营活动现金流入小计266,502,826.781,108,673,622.6814,550,758.1551,781,646.68
经营活动现金流出小计245,270,018.09930,908,411.12713,571,313.26475,507,932.85
经营活动产生的现金流量净额21,232,808.69177,765,211.48100,979,444.8476,273,713.83
投资活动现金流入小计55,360,205.5622,298,233.2131,617.9126,841.2
投资活动现金流出小计30,351,184.34260,500,028.3202,871,023.87152,167,618.26
投资活动产生的现金流量净额25,009,021.22-238,201,795.1-202,739,405.97-152,040,777.06
筹资活动现金流入小计100,000,000252,762,337.03243,023,091.82215,363,296.33
筹资活动现金流出小计115,911,820.57169,039,997.86136,901,049.8685,847,886.54
筹资活动产生的现金流量净额-15,911,820.5783,722,339.17106,122,041.96129,515,409.79
汇率变动对现金及现金等价物的影响----
现金及现金等价物净增加额30,330,009.3423,285,755.554,362,080.8353,748,346.56
期末现金及现金等价物余额305,060,446.4274,730,437.06255,807,762.34305,194,028.07
最新报告期:2025-05-07
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
中信证券陈竹,王凯旋,韩世通1.191.331.482025-05-07
华安证券谭国超1.321.521.752025-05-06
TOP↑